| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Greene John is a Director at CRISPR Therapeutics AG. Recent SEC Form 4 filings include 1 buy and 0 sells.
Estimated insider holdings value: $379K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26, 2025 | CRSP Crispr Therapeutics AG | Director | Buy | 7,000 | $44.85 | $313,947.90 | New | -15.4% | +39.1% |